Related references
Note: Only part of the references are listed.Formation of 3D Cholesterol Crystals from 2D Nucleation Sites in Lipid Bilayer Membranes: Implications for Atherosclerosis
Neta Varsano et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Role of cholesterol crystals in atherosclerosis is unmasked by altering tissue preparation methods
Mojdeh Nasiri et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2015)
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
Jennifer G. Robinson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Christopher P. Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Eroded Versus Ruptured Plaques at the Culprit Site of STEMI
Francesco Sala et al.
JACC-CARDIOVASCULAR IMAGING (2015)
Relationship between cholesterol crystals and culprit lesion characteristics in patients with stable coronary artery disease: an optical coherence tomography study
Shunichi Nakamura et al.
CLINICAL RESEARCH IN CARDIOLOGY (2014)
OxLDL induces endothelial dysfunction and death via TRAF3IP2: Inhibition by HDL3 and AMPK activators
Anthony J. Valente et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Cholesterol Crystals Induce Complement-Dependent Inflammasome Activation and Cytokine Release
Eivind O. Samstad et al.
JOURNAL OF IMMUNOLOGY (2014)
Distinct Morphological Features of Ruptured Culprit Plaque for Acute Coronary Events Compared to Those With Silent Rupture and Thin-Cap Fibroatheroma A Combined Optical Coherence Tomography and Intravascular Ultrasound Study
Jinwei Tian et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia
Dirk J. Blom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Rationale and design of the Cardiovascular Inflammation Reduction Trial: A test of the inflammatory hypothesis of atherothrombosis
Brendan M. Everett et al.
AMERICAN HEART JOURNAL (2013)
Future of Cholesteryl Ester Transfer Protein (CETP) Inhibitors: A Pharmacological Perspective
Amir Hooshang Mohammadpour et al.
CLINICAL PHARMACOKINETICS (2013)
Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
Stefan M. Nidorf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Inflammation modulates human HDL composition and function in vivo
Margarita de la Llera Moya et al.
ATHEROSCLEROSIS (2012)
Synthesis of β-cyclodextrin conjugated superparamagnetic iron oxide nanoparticles for selective binding and detection of cholesterol crystals
Hongguang Li et al.
CHEMICAL COMMUNICATIONS (2012)
Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
Paul M. Ridker et al.
AMERICAN HEART JOURNAL (2011)
Effect of Statins on Cholesterol Crystallization and Atherosclerotic Plaque Stabilization
George S. Abela et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Plaque Rupture and Thrombosis Are Reduced by Lowering Cholesterol Levels and Crystallization With Ezetimibe and Are Correlated With Fluorodeoxyglucose Positron Emission Tomography
Roshan Patel et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Estrogen-dependent activation of neutral cholesterol ester hydrolase underlying gender difference of atherogenesis in apoE-/- mice
Tsuyoshi Chiba et al.
ATHEROSCLEROSIS (2011)
Identification of cholesterol crystals in plaques of atherosclerotic mice using hyperspectral CARS imaging
Ryan S. Lim et al.
JOURNAL OF LIPID RESEARCH (2011)
Progress and challenges in translating the biology of atherosclerosis
Peter Libby et al.
NATURE (2011)
Imaging the subcellular structure of human coronary atherosclerosis using micro-optical coherence tomography
Linbo Liu et al.
NATURE MEDICINE (2011)
A Prospective Natural-History Study of Coronary Atherosclerosis.
Gregg W. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Potential role of the lipoxygenase derived lipid mediators in atherosclerosis: leukotrienes, lipoxins and resolvins
Martin Hersberger
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2010)
Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammation
George S. Abela
JOURNAL OF CLINICAL LIPIDOLOGY (2010)
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Peter Duewell et al.
NATURE (2010)
TNF alpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure
Petra Kleinbongard et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Effect of Cholesterol Crystals on Plaques and Intima in Arteries of Patients With Acute Coronary and Cerebrovascular Syndromes
George S. Abela et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Physical factors that trigger cholesterol crystallization leading to plaque rupture
Ameeth Vedre et al.
ATHEROSCLEROSIS (2009)
ACAT Inhibition and Progression of Carotid Atherosclerosis in Patients With Familial Hypercholesterolemia The CAPTIVATE Randomized Trial
Marijn C. Meuwese et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Cardiovascular manifestations in human immunodeficiency virus-infected patients
Chotikorn Khunnawat et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
CRAC motif peptide of the HIV-1 gp41 protein thins SOPC membranes and interacts with cholesterol
Alexander I. Greenwood et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2008)
Macrophage-specific transgenic expression of cholesteryl ester hydrolase significantly reduces atherosclerosis and lesion necrosis in Ldlr-/- mice
Bin Zhao et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Free cholesterol in antherosclerotic plaques: where does it come from?
Frank D. Kolodgie et al.
CURRENT OPINION IN LIPIDOLOGY (2007)
Enhanced levels of oxidized low-density lipoprotein prime monocytes to cytokine overproduction via Upregulation of CD14 and toll-like receptor 4 in unstable Angina
A. Fratta Pasini et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Preventive cardiology: the SHAPE of the future - A synopsis from the screening for heart attack prevention and education (SHAPE) Task Force report
Morteza Naghavi
HERZ (2007)
Effect of ACAT inhibition on the progression of coronary atherosclerosis
SE Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Gout-associated uric acid crystals activate the NALP3 inflammasome
F Martinon et al.
NATURE (2006)
Cholesterol crystals rupture biological membranes and human plaques during acute cardiovascular events - A novel insight into plaque rupture by scanning electron microscopy
GS Abela et al.
SCANNING (2006)
Cholesterol crystals cause mechanical damage to biological membranes: A proposed mechanism of plaque rupture and erosion leading to arterial thrombosis
GS Abela et al.
CLINICAL CARDIOLOGY (2005)
Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-α activator fenofibrate
P Gervois et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins
N Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Terminology for high-risk and vulnerable coronary artery plaques - Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece
JA Schaar et al.
EUROPEAN HEART JOURNAL (2004)
Age-associated decrease in plasma cholesterol and changes in cholesterol metabolism in homozygous watanabe heritable hyperlipidemic rabbits
M Shiomi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2000)
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
